PolyNovo share price shoots higher on coronavirus update

The PolyNovo Ltd (ASX:PNV) share price is storming higher on Wednesday after releasing a coronavirus update…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The PolyNovo Ltd (ASX: PNV) share price has burst higher during morning trade.

At the time of writing the dermal regeneration focused medical device company's shares are up 6% to $2.19.

Why is the PolyNovo share price shooting higher?

Investors have been buying the company's shares this morning following the release of an update on the impact the coronavirus is having on its business.

As you might have guessed from the share price reaction, PolyNovo advised that the coronavirus outbreak is unlikely to have a direct impact on its business or sales going forward.

This is partly because the company does not source raw materials from China and has multiple supplier redundancy built into its supply chain. This is expected to prevent any significant supply chain disruption.

In addition to this, management notes that the company currently has enough raw materials to run two shifts of production.

These two production shifts are scheduled from April 2020 and are expected to produce enough inventory to fulfil the anticipated demand for the remainder of the year.

Furthermore, the company has sufficient inventory of finished product on shelf in the US, Australia, and New Zealand, and adequate stocks in the UK/EU to meet anticipated sales for a significant period.

Another positive is that unlike Cochlear Limited (ASX: COH), which has seen hearing implant surgeries deferred, PolyNovo's products are not used in elective surgeries. They are used in emergency, trauma, or extensive surgery applications, which management expects to continue in a virus challenged world.

PolyNovo's Chief Executive Officer, Paul Brennan, said, "We are taking a disciplined approach to the virus and we are careful to be realistic and not have undue optimism. We are vigilant about our business and will adapt to any changes at short notice and as they arise, taking decisive action if required."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Coronavirus News

Man with his hand on his face looking at a falling share price chart on a tablet.
Share Market News

ASX 200 stocks dive 2.4% in worst trading day since Ukraine crisis hit

It's not a good start to the week for the market.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand. representing the falling Air New Zealand share price today
Travel Shares

Borders just reopened so why is the Flight Centre (ASX:FLT) share price falling today?

Experts believe it may take several years for tourism levels to rebound to pre-pandemic numbers.

Read more »

A worker in hi vis gear holds his hand up saying no.
Coronavirus News

Own BHP (ASX:BHP) shares? Here's how the ASX 200 miner is battling COVID

Mining unions have not generally supported mandatory vaccinations.

Read more »

Female worker sitting desk with head in hand and looking fed up
Coronavirus News

Here's what Rio Tinto (ASX:RIO) boss says is 'causing some challenges' right now

The Omicron variant is spreading in Western Australia.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Coronavirus News

Why are ASX COVID test shares climbing today?

COVID-19 tests are in focus again today.

Read more »

a girl stands in an apple orchard holding two red apples in raised arms with a happy, celebratory look on her face with a large smile and a pretty country background to the picture.
Economy

CBA reveals the Australian economy's leading state amid COVID surge

The states and territories have all been impacted by the pandemic.

Read more »

Rapid Antigen Test taking place.
Share Market News

Why is Ellume hitting headlines today?

Brisbane-based diagnostics developer Ellume is back in the headlines.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Share Market News

Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

Read more »